The central nervous system (CNS) is a site of relative immunological privilege; despite this it can be a target of the immune system under certain conditions. For example, adenoviral vectors elicit an immune response strong enough to result in antigen elimination, in immunologically primed animals. Fas ligand (FasL) contributes to the immune privilege of certain tissues by inducing apoptosis in activated T cells. We therefore investigated whether local overexpression of FasL could downregulate the immune response to adenovirus in the brain. Adenoviral vectors expressing FasL (AdFasL) and the reporter gene b-galactosidase (Adbgal) were co-injected into the striatum of naïve or immunologically primed mice. A co-injection of an adenovirus lacking a transgene (Ad0) and Adbgal acted as a control. At 2 weeks after inoculation, reporter protein expression was significantly reduced with the AdFasL:Adbgal combination compared with the Ad0:Adbgal controls. This was accompanied by a strong inflammatory cell infiltrate, local demyelination and upregulation of pro-inflammatory cytokine gene expression. These experiments demonstrate that FasL overexpression elicits a pro-inflammatory response in the CNS rather than immunosuppression. This was characterized by chronic inflammation and accelerated loss of transgene expression. Induction of such an unexpected pro-inflammatory response caused by introducing FasL may be a peculiarity of the relative immunoprivilege of the unique environment of the brain.
Introduction
The central nervous system (CNS) is regarded as an immune privileged site due to limited interaction with cells of the immune system. However, in the brain, an intense inflammatory response can occur against a wide variety of both CNS and non-CNS antigens. [1] [2] [3] Normally, only activated T cells cross the blood-brain barrier, regardless of antigen specificity. 4 If activated T cells specific to a foreign antigen in the brain exist in the circulation, the resultant delayed-type hypersensitivity response is sufficient to eliminate this antigen. 2, [5] [6] [7] After injection of an adenoviral vector in the periphery in naïve mice, transgene expression is transient, declining over a period of weeks. [8] [9] [10] [11] In contrast, transgene expression is maintained for several months in the CNS. [12] [13] [14] Long-lasting transgene expression may be observed in T-cell deficient, 10, 15 neonatal, 16 or immunosuppressed animals, [17] [18] [19] implying that the cellular immune response plays a key role in regulating transgene expression. [20] [21] [22] [23] Fas ligand (FasL), a member of the tumour necrosis factor family, is important in activation-induced cell death and maintenance of immune homeostasis. [24] [25] [26] FasL expression is restricted to specific cell types and crosslinking of the Fas receptor results in apoptosis of the target cell. [27] [28] [29] FasL is constitutively expressed at certain immunologically privileged sites (for example, Sertoli cells of the testes and in the anterior chamber of the eye) and plays a crucial role in maintaining this immune privileged status. Testis grafts derived from mice expressing FasL survived indefinitely when transplanted under the kidney capsule of allogeneic animals 30 and inflammatory cells entering the eye in response to viral infection underwent apoptosis that was dependent on FasL. 31 When Sertoli cells were co-transplanted in the brain with xenografts the Sertoli cells produced localized immunosuppression allowing the xenografts to survive, 32 and Sertoli cell allografts and porcine Sertoli cell xenografts survived for at least 2 months when directly transplanted into the rat striatum. General immunosuppression was not used, implying that expression of FasL by the Sertoli cells was sufficient to induce a localized immunosuppression in the brain. 32, 33 Co-transplantation of rat Sertoli cells with ventral mesencephalic cells into a dopamine-depleted rat striatum promoted a greater survival of dopaminergic neurons compared to controls, 34 suggesting that FasL expression by the Sertoli cells within the graft downregulated local immune responses. Adenoviral vectors, while eliciting long-term transgene expression in the CNS, do themselves cause local inflammatory responses. The work described in this paper investigated whether local FasL expression could downregulate the inflammatory response to adenoviral vectors in the CNS. The nature of the resultant inflammatory response was investigated in immunologically primed or unprimed mice and studied using immunohistochemical techniques and RT-PCR.
Results
Despite yielding prolonged transgene expression in the CNS, adenoviral vectors can elicit chronic inflammatory responses. Local expression of FasL is known to enhance the survival of foreign tissue grafts in the CNS. We therefore wished to test the hypothesis that local adenoviral expression of FasL could downregulate the inflammatory response to adenoviral vectors in the brain.
Verification of FasL expression from AdCMVFasL
The expression of FasL was determined in vitro firstly by RT-PCR. First-strand synthesis was assessed via PCR to detect the housekeeping gene, GAPDH, at 30 cycles of amplification. GAPDH expression was clearly evident in all cDNA samples (data not shown). Only those cells infected with AdCMVFasL gave a 723 base pair product corresponding to FasL mRNA expression ( Figure 1a ). Each PCR product was sequenced to confirm that this was identical to the published sequence for FasL. Biological activity was then studied using an apoptotic assay. The presence of FasL was sufficient to induce apoptosis in the target (Jurkat) cells. Induction of apoptosis was significantly higher in samples that had been incubated with AdCMVFasL than in controls (Figure 1b) , as indicated by highly condensed, fragmented chromatin. The Jurkat leukaemic hybridoma T cell line expresses the Fas receptor and is consequently susceptible to FasL-mediated apoptosis if the ligand is present and functionally active, as produced by the FasL-expressing adenovirus.
Transgene expression and the inflammatory response elicited following injection of control vectors
In the first set of experiments we investigated the inflammatory response to co-injections of control adenoviral vectors (Ad0 and Adbgal) into the striatum of naïve mice. When the Ad0 and Adbgal viruses were inoculated into the striatum of naïve mice, b-galactosidase expression was observed at the earliest time point of 3 days after injection, and was strongest from 3 to 7 days postinjection. Positive cells were found in and around the injection site. Expression was also observed in the corpus callosum and in some cases in the ventricular ependymal cells. The latter probably resulted from a leak of the virus at the injection site into the lateral ventricles. In this instance, the expression was stronger, as was the accompanying inflammatory response (data not shown). A decline in expression was observed from 14 days but this level was maintained for at least 70 days after injection, which was the latest time point studied (Figure 2a-c) . These results are consistent with previous observations. A low-level of expression of leucocyte common antigen (LCA) and major histocompatability complex (MHC) class I expression was observed in and around the injection site in the right caudate, the corpus callosum and along the needle track in the cortex. Infiltrating macrophages and T cells could also be observed forming a few perivascular cuffs and infiltrating the brain parenchyma (Figure 3a) . From 7 to 14 days after injection an intense upregulation of LCA and MHC class I was observed on many infiltrating cells in the parenchyma, the corpus callosum and in perivascular cuffs. FA/11 + macrophages and activated microglia were observed in dense clusters in the parenchyma. T-cell infiltration was maximal by day 14 and found throughout the injection site ( Figure 4 ). However, from 21 to 70 days postinjection, a rapid decline in the inflammatory response was observed. There were markedly fewer perivascular cuffs and infiltrates throughout the injection site in the parenchyma. This was also accompanied by weak expression of both LCA and MHC class I, indicating a significant decrease in the number of leukocytes in and around the injection site. By 70 days after injection only a small number of LCA and MHC class I expressing cells were observed and the few infiltrating cells present in the parenchyma consisted predominantly of macrophages (Figure 5a and b) . A loss of myelin pallor, as determined by luxol fast blue staining, was not observed in any of the animals studied at these time points (data not shown).
The mRNA expression profile for a range of cytokines was also examined to further study the inflammatory response and to compare with our observations, as detected by immunocytochemistry. Immunomodulatory role of FasL in the CNS EL Regardsoe et al First-strand synthesis was assessed via PCR to detect the housekeeping gene, GAPDH. At 30 cycles of amplification, GAPDH expression was clearly evident in all cDNA samples as a distinct 982 base pair product (Figure 6a ). Successful first-strand synthesis for each sample had been achieved. This also demonstrated that an equivalent amount of cDNA was used in each PCR reaction; therefore, the mRNA expression profile for each cytokine could be compared using semiquantitative RT-PCR.
The mRNA expression profile of interferon-g (IFN-g) was then examined for these samples. Clear bands of IFN-g were detected as a 459 base pair product from 35 cycles of PCR. The mRNA expression profile of IFN-g showed only a band at 14 days after injection (Figure 6b ). Activated CD4 + and CD8 + T lymphocytes are the principle source of IFN-g, although natural killer cells can also secrete this cytokine. The peak of the inflammatory response was around 14 days after injection, as detected by immunohistochemistry. The detection and upregulation of IFN-g at 14 days postinjection is in accordance with the histological findings.
Tumour necrosis factor-a (TNF-a) mRNA was detected as a 513 base pair product at 35 cycles of PCR amplification. TNF-a mRNA was detected faintly at 3 and 7 days postinjection. A strong upregulation was observed at 14 days after injection, but not at any other time point studied (Figure 6c ). The peak of mRNA expression for TNF-a was the same as observed for IFNg. This is not surprising as macrophages and activated lymphocytes secrete TNF-a, and these cell types were observed as early as 3 days after injection. TNF-a has many roles in brain inflammation and injury, most notably in increasing extravasation of leukocytes, oligodendrocyte damage and demyelination and induces the expression of other cytokines involved in inflammation.
Bands of interleukin-2 receptor (IL-2R) were detected at 33 cycles of PCR as a 501 base pair product. IL-2R mRNA was detected as a faint band at 3 and 7 days (Figure 6d ). This increased in intensity by 14 days, however, had waned again by 21 days after injection. The expression of IL-2R appears to be specific for activated T lymphocytes; however, resting T cells do When AdFasL and Adbgal were co-injected, bgalactosidase expression was again detectable at 3 days after injection and was maximal by 7 days postinjection. There was no quantitative difference in the levels of bgalactosidase expression for animals in this experiment compared with those in the previous experiment at these time points (data not shown). However, by 14 days postinjection, a dramatic reduction in the level of bgalactosidase expression was observed. This loss in expression was maintained for the remaining time points, with only a few expressing cells observed in one animal at day 21 and 35 days and no positive cells detected at day 70 (Figure 2d-f ). This decline in transgene expression was significantly different from that seen in the control experiment when Ad0 was coinjected with Adbgal instead of AdFasL and is summarized in Figure 7 .
Qualitative and quantitative differences in the inflammatory response were also observed between animals in this and the previous experiment. An extensive upregulation of LCA and MHC class I expression was observed on infiltrating cells and the vascular endothelium throughout the injection site from 3 days postinjection. Substantial perivascular cuffing and parenchymal infiltration of T cells and FA/11-positive macrophages also accompanied this, indicating a marked inflammatory response (Figure 3b-d) .
From 7 to 14 days after injection no qualitative or quantitative differences between the animals in this experiment and those in the previous experiment were found. An intense upregulation of LCA and MHC class I was observed, with many infiltrating cells in the parenchyma, the corpus callosum and in perivascular cuffs. However, from 21 to 70 days postinjection, qualitative differences in the inflammatory response were again considerable between the two groups. In this experiment a more severe and widespread inflammation was observed from 21 days, and was still very evident 70 days after injection. All later time points continued to show dense clustering of both MHC class I-positive and LCApositive cells in and around the injection site. Substantial perivascular cuffing and parenchymal infiltration of macrophages and T cells was observed (Figure 5c-e) .
Luxol fast blue staining showed evidence of myelin pallor in one animal at 35 days and two at 70 days. This was illustrated by a loss of the patches and altered structure in the caudate nucleus, at the site of inflammation. Structure and definition were still maintained in the contralateral (uninjected) side of the brain (Figure 5f ). The mRNA expression profile of IFN-g was also studied in this experiment. A faint band was observed at 3 days, which increased in intensity at 7, 14 and 21 days after injection. The band intensity was reduced by 35 days and could not be detected by 70 days postinjection (Figure 6b ). The detection of IFN-g mRNA as early as 3 days postinjection under experimental conditions is in keeping with the presence of inflammatory mediators, in particular, T lymphocytes and macrophages infiltrating the brain parenchyma, as detected by immunohistochemistry.
TNF-a mRNA was detected as a lower intensity band at 3 days after injection of the FasL vector, increasing in intensity at 7, 14 and 21 days before waning at 35 and 70 days after injection (Figure 6c ). The mRNA expression profile for TNF-a was therefore very similar to that observed for IFN-g.
The relative intensities of IL-2R mRNA expression followed the same pattern as that observed for IFN-g and TNF-a. Bands were detected as early as 3 days postinjection and could still be observed at 70 days (Figure 6d ). Fainter bands indicating the presence of IL-2R mRNA could be detected in the contralateral side in a few samples (at 14 and 21 days). This has most likely resulted from an inaccurate bisection of the brain hemispheres or inadequate perfusion of the neural tissue. Leukocyte infiltrates were detected by immunohistochemistry from 3 to 70 days under these conditions; therefore, the expression of IL-2R mRNA observed here correlates well with the histological analysis.
In summary, in comparing these experiments, an intense expression of b-galactosidase was observed for both groups 3 and 7 days postinjection. However, significant quantitative differences were observed between these groups from 14 days after injection and for the remaining time points. Under control conditions, transgene expression was maintained for at least 70 days after injection; however, those animals co-injected with AdFasL and Adbgal showed an accelerated loss of transgene expression from 14 days onwards ( Figure 7 ). Significant quantitative differences in the histological findings detecting the different inflammatory markers for both groups were also observed from 21 days after injection. The inflammatory response for three animals was assessed per time point and is summarized in Figure  8 . In the control group a transient inflammatory response was seen, which had declined significantly in intensity by 21 days after injection. However, in the experimental group (AdFasL:Adbgal) a persistent inflammatory response was observed, which was evident for at least 70 days after injection. This finding is consistent with previous experiments. 13, 35 Inflammation was not observed on the contralateral side of the brain in any of the sections studied. 
Transgene expression and the inflammatory response elicited following injection of control vectors in primed mice
Previous work has shown that if animals are immunologically primed in the periphery by a foreign antigen prior to inoculation in the CNS, by the same antigen, this leads to a more robust immune response both qualitatively and quantitatively in the CNS.
Here the pattern of transgene expression for mice primed subcutaneously in the periphery with Adbgal 7days prior to receiving a co-injection of Ad0 and Adbgal was very similar to that seen in the previous experiment, in which animals were inoculated with AdFasL and Adbgal. A dramatic loss in transgene expression to almost undetectable levels by 14 days was observed ( Figure 9 ). The inflammatory response was markedly upregulated by 3 days postinjection, was maximal by 14 days and persisted for at least 70 days. Myelin pallor in the injection site from 35 days after injection was also evident. Quantitative analysis of the inflammatory markers studied was performed and demonstrates a striking similarity in the immune response for both the experimental and control conditions ( Figure 10 ). This is in accordance with previous work demonstrating an increased and prolonged inflammatory response under primed conditions. 22 The pattern of cytokine upregulation for immunologically primed mice here was again very similar to that seen in the previous experiment, in which animals received only a CNS co-injection of the AdFasL:Adbgal viral vectors. An upregulation of the pro-inflammatory + and (e) CD8 + T cell infiltration under control conditions was greatest by 14 days, paralleling the IL-2R cytokine profile. However, samples infected with the Fas ligand expressing adenovirus demonstrated a marked upregulation of both CD4 + and CD8 + from the earliest time point studied reflecting the kinetics of the response seen in primed animals.
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EL Regardsoe et al cytokines, IFN-g and TNF-a, was observed from as early as 3 days after injection, and persisted until the later time points studied. IL-2R mRNA was also detected from as early as 3 days. Taken together these findings were in accordance with the immunohistological data ( Figure 11 ).
Transgene expression and the inflammatory response elicited following co-injection of a FasL expressing vector and a control vector in primed mice
The pattern of transgene expression for primed mice given a co-injection of AdFasL and Adbgal did not differ from the above description ( Figure 9 ) and confirmed that upregulation of FasL in the CNS was unable to downregulate the local inflammatory response elicited following priming of the animals. There were no qualitative or quantitative differences observed for the inflammatory markers between the animals in this group and those in the previous group, and both were characterized by myelin pallor in the injection site from 35 days after injection ( Figure 10 ). The pattern of cytokine upregulation was very similar to that observed under control conditions in primed mice, with IFN-g detected from as early as 3 days and persisted until the latest time point studied. This was accompanied by the presence of TNF-a and IL-2R at all time points studied and is in agreement with the immunohistological findings ( Figure 11 ).
Discussion
The known roles of FasL in activation-induced cell death and in the maintenance of immune privilege made it a candidate gene for downregulation of the local immune response generated towards adenoviral vectors in the brain. We therefore asked the question whether an adenoviral vector expressing FasL could indeed abrogate the local inflammatory response to the vector. In these experiments in immunologically naïve mice, FasL markedly upregulated the inflammatory response and despite an initial strong expression of the bgalactosidase transgene this was rapidly downregulated. This was in direct contrast to a transient inflammatory response and persistence of transgene expression observed under control conditions. Under immunologically primed conditions neither a qualitative nor quantitative difference in the inflammatory response was observed following FasL expression compared with naïve animals. . Error bars indicate mean7s.e.m. *Significantly different from controls. There was no significant difference, except at the early time points for MHC class I and macrophages.
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This suggests that the degree to which FasL is proinflammatory is similar to that seen following a peripheral priming stimulus. This pro-inflammatory response involved upregulated expression of the inflammatory markers LCA and MHC class I, infiltration of macrophages and CD4 + and CD8 + T cells, all of which could be detected as early as 3 days postviral injection and persisted until 70 days. INF-g, TNF-a and IL-2R mRNA could also be detected from 3 days postinjection until 70 days. This could also be due to the presence of infiltrating NK cells. In controls the maximal immune response in terms of both infiltration of leucocytes and upregulation of cytokines was detected between 7 and 14 days postinjection. Thereafter a rapid decline in the inflammatory response was seen. In addition, there was evidence of immunopathology in animals injected with FasL expressing vectors with evidence of myelin pallor at 35 and 70 days, but not in controls. Previous work in this laboratory and the work of others have shown that immunological priming in the periphery with the same antigen results in a greatly increased immune response to that antigen in the brain, in spite of the brains normal immunoprivilege. When animals were given a peripheral injection of adenovirus, elevated MHC class I and II expression and infiltration of macrophages and T cells were found in the injection site when the virus was subsequently injected in the brain. All animals had severe inflammation by 14 days and by 35 days they showed a total lack of myelin in restricted areas. Peripheral priming in this way is the principal means by which a severe inflammatory response is induced in an immunoprivileged site such as the brain. 2, 36 However, in these experiments the local expression of FasL in the CNS appears also to be pro-inflammatory and of a similar intensity to the inflammation observed following peripheral priming. It is important to note however that priming only reactivates inflammation in the brain if the virus injected in the brain is a first-generation vector. This response is not seen if the initial CNS injection is with a high capacity adenoviral vector. 37 What is the likely mechanism of this pro-inflammatory response? It is conceivable that following infection upregulation of the receptor on those cells expressing the ligand produces a local environment susceptible to apoptosis and cell death. The local production of cytokines may initiate upregulation of the receptor on cells expressing the ligand, resulting in a cascade of events leading to apoptosis of infected cells. Studies using the TUNEL assay would determine what degree of cell death was due to an apoptotic affect. Cell death by apoptosis was not examined in these experiments, but the two pro-inflammatory cytokines IFN-g and TNF-a were found to be upregulated from as early as 3 days. IFN-g is known to upregulate the expression of MHC molecules on cell types in the CNS. [38] [39] [40] TNF-a contributes to the activation of T lymphocytes and drives additional cytokine production. The role of IFN-g and TNF-a could be potentially pivotal in controlling the inflammation and pathology seen following infection with FasL. Further study using athymic nude mice (T cell deficient) would help determine whether these T-cellderived cytokines do indeed play a role. Multiple marking for immunohistochemistry might also determine whether the inflammatory markers such as MHC class I were being expressed on parenchymal or infiltrating cells, or indeed both, and might help establish a more complete picture regarding the inflammation surrounding the injection of the FasL expressing adenovirus. In addition, it is possible that FasL transgene expression leads to the loss of regulatory T cells, contributing to a vigorous and prolonged immune response.
Other studies have also reported a pro-inflammatory action of FasL. The consequences of enforced FasL expression in striated muscle of transgenic mice resulted in mild leukocyte infiltration. Induced expression of the cytokines TNF-a, IL-1b, IL-6 and TGF-b accompanied the pro-inflammatory changes, which was shown to be dose dependent. 41 When FasL expression was engineered in various murine transplants in the hope of providing immune tolerance, FasL was frequently found to induce inflammation and allograft rejection. 42, 43 Inflammation appeared to depend on production of neutrophil chemoattractants by Fas-stimulated, apoptotic cells in the allograft microenvironment, rather than any direct effect of FasL on the neutrophils themselves. 44 FasL upregulates the expression of various chemokines and cytokines (including IL-8) in different cell types. 45 Local induction of the Fas receptor pathway from within rat vascular smooth muscle cells by overexpression of the Fasassociated death-domain protein triggered macrophage recruitment to the area of apoptosis in vivo. 45 Vascular smooth muscle cells upregulated a number of cytokines/ chemokines in response to Fas ligation, including IL-8, IL-1a, MCP-1, GRO-1 and IL-6. Thus, locally excessive FasL-mediated apoptosis may not be 'silent' with respect to the immune system, but may instead be 'flagged' for recruitment of inflammatory cells. 44 In the brain reactive astrocytes have been shown to express high levels of Fas receptor and can respond to FasL by apoptosis or IL-8 production. 46 Brain lesions of multiple sclerosis patients have shown enhanced expression of Fas and FasL on astrocytes, oligodendrocytes, microglia/macrophages and T cells. 47, 48 It would therefore be interesting to perform studies, which controlled the amount of FasL being expressed from the adenoviral vector to see if the dose-response effect of FasL could be mimicked under these conditions. An inducible adenoviral vector expressing FasL would provide the mechanism through which this could be studied.
A potential application for the pro-inflammatory nature of FasL has been reported in several papers regarding tumour models. Tumours expressing FasL are rejected, probably due to an infiltration of neutrophils and subsequently T lymphocytes. Blocking the interaction between the Fas receptor and FasL inhibited the infiltration of neutrophils and consequently prevented tumour graft rejection. [49] [50] [51] [52] A potent antitumour effect of FasL was demonstrated in a syngeneic transplantation model, whereby murine Fas-negative tumour cells, transfected with FasL cDNA then subsequently transplanted into a syngeneic recipient, were rejected via a neutrophil-mediated primary rejection event. 51 FasL produced locally by the tumour cells was responsible for the accelerated recruitment of neutrophils. Following injection into the eye, tumours expressing soluble FasL failed to trigger inflammation and grew progressively. By contrast, tumours expressing only membrane-bound FasL initiated vigorous neutrophil-mediated inflammation, terminated immune privilege and were completely rejected. The rejection coincided with activation of both the innate and adaptive immunity and was dependent on the expression level of FasL, as measured by flow cytometry. Whether or not, therefore, FasL is proinflammatory may be dependent on the expression level. In the present study, FasL was constitutively expressed using a strong viral promoter and it may be that in our experiments expression was above the threshold level required for initiating inflammation.
The initial hypothesis was that FasL may exert an immunosuppressive effect on the immune response generated towards an adenoviral vector in the brain, but this has not been substantiated in these experiments. The role of FasL remains controversial due to studies that indicate FasL is both pro-and anti-inflammatory; this study confirms its pro-inflammatory nature. However, a more refined strategy of using antigen-presenting cells to express FasL may be a more promising way to achieve immunosuppression. FasL expressing APCs were shown to eliminate infiltrating T cells in the liver, kidney, joint and salivary gland in autoimmune mice. 53 Regulated cell-specific expression of FasL using the local antigenpresenting cells of the brain (microglia) could be a potential strategy to achieve CNS immunosuppression.
Materials and methods

Viruses
The E1-deleted adenoviral vectors used in this study were Ad0, a control E1-deleted vector minus a transgene but containing all other viral genes, Adbgal, which contains the lacZ gene (encoding b-galactosidase) also under control of the cytomegalovirus (CMV) promoter, and AdFasL, which expresses murine FasL under control of the CMV promoter. AdFasL was a kind gift from Dr Libermann.
Viruses were purified twice by CsCl ultracentrifugation, to remove wild-type virus contamination, then buffer-exchanged on a Sephadex PD10 column (Pharmacia, St Albans, UK) with a 10 mM Tris-HCl (pH 7.5), 1 mM MgCl 2 solution. The viral prep was then passed through a sterile 0.2 mm filter, aliquoted and stored at À701C until use. Viral vectors were screened for wild-type adenoviral contamination by serial amplification using HeLa cells. Titres were determined by plaque assay on HEK 293 cells, and were 1 Â 10 10 pfu/ml for AdFasL, 1 Â 10 9 pfu/ ml for Adbgal and 4 Â 10 9 pfu/ml for Ad0.
mRNA expression of FasL
Detection of Fas ligand mRNA expression was carried out by RT-PCR on total cellular RNA extracted using TRIZOL Reagent from the monkey kidney cell line (COS cells) infected with AdO, AdCMVbgal or AdCMVFasL, for 24 h. One flask containing COS cells was left uninfected as a control. Total RNA was DNaseI treated to eliminate genomic DNA, subjected to reverse transcription at 371C with oligo (dT) [8] [9] [10] [11] [12] primers and M-MLV reverse transcriptase, followed by RNaseA treatment at 371C for 15 min. Controls for the RT procedure, omitting the RT reagent, were also included. PCR amplification of cDNAs using the GAPDH and FasL specific primers consisted of an initial denaturation of 951C for 5 min, followed by commencement of the iterative loop: denaturation at 951C for 1 min, annealing at 601C for 1 min and extension at 721C for 1 min for 35 cycles. Negative controls were performed without reverse transcriptase and without RNA. The obtained PCR product was sequenced using the same primers (DNA Sequencing Facility, Department of Biochemistry, Oxford University, UK).
Verification of biological activity of FasL expressed from AdCMVFasL
COS cells were plated at a density of 5 Â 10 6 cells/ml 24 h prior to infection at a MOI (multiplicity of infection) ¼ 100, with either AdCMVFasL or AdCMVbgal. The Jurkat leukaemic hybridoma T-cell line was used as the target cell as this expresses the Fas receptor. At 24 h postinfection each sample was incubated with 1 Â 10 7
Jurkat cells for a maximum of 6 h, samples taken at two hourly intervals. A total of 100 mg/ml acridine orange and 100 mg/ml ethidium bromide, both prepared in DPBS, were mixed in a 1:1 ratio. In all, 10 ml of each sample was taken and added to 250 ml dye mix. Cells
Immunomodulatory role of FasL in the CNS EL Regardsoe et al were examined under an inverted Leica fluorescent microscope. To quantify the percentage of apoptotic cells in each sample, a minimum total number of 400 cells were counted in each instance (n ¼ 3 for each time point) and recorded as live, apoptotic or necrotic. The percentage of apoptotic cells was calculated, and the data expressed as means795% confidence interval. Statistical analysis was carried out using an analysis of variance (ANOVA). A P-value of less than 0.05 was required to reject the null hypothesis (no significant effect). If an effect was determined as significant, a post hoc test, the Fisher's protected least significant difference (Fisher's PLSD), was carried out to determine which particular means differed from another.
Animals
Mice were conventionally housed with food and water provided ad libitum in the Department of Human Anatomy and Genetics animal facility, Oxford, UK. All mice were originally derived from an F 1 hybrid between C3H/He and 101/H mice, were 3 months of age and had the MHC haplotype H-2 k .
Surgical procedures
Stereotactic co-injection of viral vectors into the striatum was carried out as previously described. 13 Under general anaesthesia with ketamine (Parke-Davis, 100 mg/kg i.p.) and xylazine (Bayer, 10 mg/kg i.p.) adult mice (aged B3 months) were placed and fixed in a stereotaxic injection frame, then injected into the right striatum (bregma, lateral 2.25 mm, down 2.5 mm from dura). Injections were carried out over 2 min and the micropipette was left in place for 5 min before withdrawal. Six mice per time point (3, 7, 14, 21, 35 and 70 days) were killed after intracerebral injection. Unprimed mice were co-injected with either 0.5 ml of 1 Â 10 6 pfu of Ad0 and Adbgal or coinjected with 0.5 ml of 1 Â 10 6 pfu of AdFasL and Adbgal. For primed experiments, mice were given a subcutaneous injection of 250 ml of 10 mM Tris-HCl (pH 7.5), 1 mM MgCl 2 containing 4 Â 10 6 pfu of Adbgal 7 days prior to the intracerebral injection. Mice were then coinjected with either the Ad0 and Adbgal viral vectors as above, or AdFasL and Adbgal.
Transcardiac perfusion using heparinized saline (0.9% NaCl containing 1 ml/l heparin sulphate solution (CP Pharmaceuticals, Wrexham, UK)) was then carried out. This was to ensure that for the RT-PCR studies, only those immune cells located in the brain parenchyma remained and the contralateral side of the brain could be used as a control. Three brains were removed for immunohistochemical procedures, frozen in OCT Tissue-Tek (Sakura Finetechnical) embedding compound and stored at À701C. The remaining three were used for total RNA extraction. A block of neural tissue around the injection site was removed, bisected to separate the two hemispheres, snap frozen on dry ice and stored at À701C.
Immunohistochemistry
The procedure used has been previously described. 13 Serial sections were stained with various rat anti-mouse monoclonal antibodies: TIB122 (LCA (CD45)), 54 M1.42 (MHC class I), 55 FA/11 (macrophage-specific membrane protein macrosialin) 56 and KT3 (anti-mouse CD3). 57 All monoclonal antibodies were generously provided by the MRC Cellular Immunology Unit (Oxford, UK) and used as tissue culture supernatants. Control sections that omitted the primary antibody were consistently negative. Some sections were stained with luxol fast blue for localization of myelin. A quantitative analysis was performed to assess the amount of inflammatory markers, using the Contron Data Image Analyser (IBAS 2000) system. The total area of staining was measured for all the sections from each brain using the image analyser, then the mean area for each time point (n ¼ 3) was calculated per condition and plotted as a histogram. Data are expressed as means7s.e.m. Statistical analysis was carried out using a two-tailed, unpaired T-test.
b-Galactosidase detection and quantitation
Sections were postfixed in cold 100% ethanol for 15 min at 41C, then incubated in X-gal (5-bromo-4-chloro-3-indolyl-b-galacto-pyranoside) solution (composed of 50 mM potassium ferricyanide, 50 mM potassium ferrocyanide, 50 mM MgCl 2 ; 1% sodium deoxycholate, 1% Nonidet-P40, 1 mg/ml X-gal in PBS) for 3 h at 321C. Sections were counterstained with carminic acid, (IBAS 2000) system. The total area of blue staining was measured for all the sections from each brain using the image analyser, then the mean X-gal area for each time point (n ¼ 3) was calculated per condition and plotted as a histogram. Data are expressed as means795% confidence interval. Statistical analysis was carried out using an analysis of variance (ANOVA). A P-value of less than 0.05 was required to reject the null hypothesis (no significant effect). Fisher's PLSD was carried out to determine which particular means differed from another.
RT-PCR and cDNA synthesis
This technique was performed as established in the laboratory and previously described. 58 All reactions were incubated in a thermal cycler (Techne Genius or Progene) for 30 cycles. The amplification program consisted of an initial denaturation at 951C for 5 min, followed by commencement of the iterative loop: denaturation at 941C for 1 min, annealing at 601C for 1 min, and extension at 721C for 1 min. A final extension of 721C for 10 min was then given. PCR conditions and primer sequences are given in Table 1 .
